The Xolair Pregnancy Registry (EXPECT): Perinatal outcomes among pregnant women with asthma treated with omalizumab (Xolair) compared against those of a cohort of pregnant women with moderate-to-severe asthma

Autor:	Santanu Mukhopadhyay, Angela E. Scheuerle, Elizabeth Andrews, John M. Thorp, Vic Spain, Deborah L. Covington, Robert Fogel, Lucie Blais, Dale T. Umetsu, Jennifer A. Namazy, Derrick Kaufman, Michael D. Cabana, Diana Sun, Joachim Veith, Sandra Lopez-Leon
Rok vydání:	2019
Předmět:	Moderate to severe Pregnancy registry Pediatrics medicine.medical_specialty business.industry Immunology Omalizumab medicine.disease Cohort Immunology and Allergy Medicine business medicine.drug Asthma
Zdroj:	Journal of Allergy and Clinical Immunology. 143:AB103
ISSN:	0091-6749
DOI:	10.1016/j.jaci.2018.12.312
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ce84dc71662b4f830e5f21b664a5ab95 https://doi.org/10.1016/j.jaci.2018.12.312 Zobrazit plný text záznamu Full Text from ScienceDirect